English | 简体中文 | 繁體中文 | 한국어 | 日本語
Monday, 7 March 2011, 15:00 HKT/SGT
Share:
    

Source: China Medical System Holdings Limited
China Medical System Accredited by 'China's Top 100 Potential Enterprises' by Forbes China for Two Consecutive Years

HONG KONG, Mar 7, 2011 - (ACN Newswire) - China Medical System Holdings Limited ("CMS" or the "Company", SEHK: 867), a leading China-based pharmaceutical services company focusing on the marketing, promotion and sale of prescription drugs, is pleased to announce that the Company was accredited as "China's Top 100 Potential Enterprises" among the list compiled by the Forbes China in February 2011. CMS has been selected on the list for two consecutive years.

Compiled by Forbes China, the "China's Top 100 Potential Enterprises" list focuses on the SMEs in China, and is the first ranking of its kind to cover the SMEs across all industries. This is the second consecutive year that CMS has won the coveted accolade for its outstanding business performance and contribution to the development of China's SMEs, and for its efforts to strive for excellence in its field.

About "China's Top 100 Potential Enterprises" by Forbes China
http://www.forbeschina.com/list/1008/more

Contact:
Hill and Knowlton Asia Ltd.

Crystal Yip  
Tel: +852 2894 6211 / 9720 6445
Email: crystal.yip@hillandknowlton.com.hk

James Wong
Tel: +852 2894 6216 / 9300 2263
Email: james.wong@hillandknowlton.com.hk



Topic: Awards
Source: China Medical System Holdings Limited

Sectors: BioTech
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

China Medical System Holdings Limited Related News
2025年7月29日 5時00分 JST
China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China
July 29, 2025 04:00 HKT/SGT
China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China
July 22, 2025 13:00 HKT/SGT
CMS Collaborates with SGX to Explore New Paradigms for Industrial Globalization and Pharmaceutical Expansion Overseas across Emerging Markets
July 18, 2025 13:00 HKT/SGT
康哲药业携手新交所 共话新兴市场产业国际化与医药出海新范式探索
July 15, 2025 17:05 HKT/SGT
耀啟新程!康哲藥業今日於新加坡交易所主板實現二次上市
More news >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575